Skip Navigation LinksHome > May 2014 - Volume 36 - Issue 4 > Significant Response to Oral Etoposide in the Treatment of a...
Journal of Pediatric Hematology/Oncology:
doi: 10.1097/MPH.0b013e318290c3b8
Online Articles: Clinical and Laboratory Observations

Significant Response to Oral Etoposide in the Treatment of an Unresectable Cardiac Sarcoma

Collins, Chelsea L. MD; Bartz, Peter J. MD; Lal, David R. MD; Segura, Annette D. MD; Woods, Ronald K. MD, PhD; Tower, Richard L. II MD

Collapse Box


Primary cardiac sarcomas are rare and carry a poor prognosis. The standard of care is complete resection. Outcomes for patients without complete resection are dismal, and the benefit of adjuvant therapy is uncertain. A 9-year-old girl presented with a large right-sided cardiac mass. After biopsy, the tumor was classified as an undifferentiated sarcoma. Resection was not feasible due to apparent invasion of the right ventricle and atrioventricular groove. Treatment with oral etoposide resulted in a 97% reduction in tumor volume and allowed for complete resection of residual tumor. She is alive with no evidence of disease 25 months from diagnosis.

Copyright © 2014 Wolters Kluwer Health, Inc. All rights reserved.


Article Tools


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.

Connect With Us


For additional oncology content, visit LWW Oncology Journals on Facebook.